Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.25.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balances at Dec. 31, 2023 $ 40 $ 1,232 $ 33,692,018 $ (29,839,841) $ 3,853,449
Balances (in Shares) at Dec. 31, 2023 39,810 1,232,333      
Shares issued as settlement of accounts payable $ 21 29,464 29,485
Shares issued as settlement of accounts payable (in Shares)   21,405      
Shares issued for vested restricted stock units $ 2 (2)
Shares issued for vested restricted stock units (in Shares)   1,667      
Net loss (178,659) (178,659)
Balances at Mar. 31, 2024 $ 40 $ 1,255 33,721,480 (30,018,500) 3,704,275
Balances (in Shares) at Mar. 31, 2024 39,810 1,255,405      
Balances at Dec. 31, 2023 $ 40 $ 1,232 33,692,018 (29,839,841) 3,853,449
Balances (in Shares) at Dec. 31, 2023 39,810 1,232,333      
Net loss         (1,136,225)
Balances at Dec. 31, 2024 $ 40 $ 1,859 35,463,769 (30,976,066) 4,489,602
Balances (in Shares) at Dec. 31, 2024 39,810 1,859,525      
Shares issued for legal settlement $ 191 148,219 148,410
Shares issued for legal settlement (in Shares)   191,250      
Shares issued for conversion of convertible loans and interest $ 55 47,228 47,283
Shares issued for conversion of convertible loans and interest (in Shares)   54,980      
Issuance of warrants in conjunction with convertible loans 1,385,000 1,385,000
Net loss (476,303) (476,303)
Balances at Mar. 31, 2025 $ 40 $ 2,105 $ 37,044,216 $ (31,452,369) $ 5,593,992
Balances (in Shares) at Mar. 31, 2025 39,810 2,105,755